Early research (Phase 1)Ended earlyNCT04485663
What this trial is testing
ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects
Who this might be right for
Chronic Hepatitis B
Aligos Therapeutics 103